Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Statins improve outcomes in high-risk prostate cancer patients treated with definitive radiation therapy

Men with high-risk prostate cancer who take statin drugs commonly used to lower cholesterol while receiving radiation therapy are less likely to have their cancer return than patients who do not take these medications, according to a study published in the March issue of the International Journal of Radiation Oncology-Biology-Physics, an official journal of the American Society for Radiation Oncology (ASTRO).

24 Mar 2011

American Heart Association: 81.8% of obese women underestimate their weight

Overweight and obese mothers and their children think they weigh less than their actual weight, according to research reported at the American Heart Association's Nutrition, Physical Activity and Metabolism/Cardiovascular Disease Epidemiology and Prevention 2011 Scientific Sessions.

24 Mar 2011

First continuous-flow total artificial heart transplant performed at THI

Doctors at the Texas Heart Institute at St. Luke's Episcopal Hospital have successfully implanted the first continuous-flow total artificial heart in a desperately ill patient facing imminent death.

24 Mar 2011

Specific plant oil may reduce belly fat in humans

Scientists have known for years that belly fat leads to serious medical problems, including diabetes, cardiovascular disease, hypertension and stroke. Now, a University of Missouri researcher has found a plant oil that may be able to reduce belly fat in humans.

24 Mar 2011

Cilag, POZEN enter license agreement to develop and commercialize MT 400

POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, today announced that it has entered into a license agreement with Cilag GmbH International, a division of Johnson & Johnson, for the development and commercialization of MT 400 in Brazil, Colombia, Ecuador and Peru.

23 Mar 2011

Xenon founder receives Canada Wightman Award for leadership in medical science

Dr. Michael Hayden, a Xenon founder and Chief Scientific Officer, has received the Canada Gairdner Wightman Award for leadership in medical science in Canada.

23 Mar 2011

Episodic physical and sexual activity associated with short-term increase in risk of acute cardiac events

An analysis of previous studies that examined whether episodic physical activity and sexual activity can act as a trigger for cardiac events found an association between these activities and a short-term increased risk of heart attack and sudden cardiac death, although the absolute risk was small and lessened among persons with high levels of regular physical activity, according to an article in the March 23/30 issue of JAMA.

23 Mar 2011

Obese teens have inflammation, insulin resistance, and high homocysteine levels despite feeling healthy

Obese teens may feel healthy, but blood tests show they have inflammation, insulin resistance, and high homocysteine levels, researchers report at the American Heart Association's Nutrition, Physical Activity and Metabolism/Cardiovascular Disease Epidemiology and Prevention 2011 Scientific Sessions.

23 Mar 2011

High-fiber diets during early adult years may reduce lifetime risk of cardiovascular disease

A new study from Northwestern Medicine shows a high-fiber diet could be a critical heart-healthy lifestyle change young and middle-aged adults can make.

23 Mar 2011

POZEN files motion for Treximet patent litigation against Par

POZEN Inc., a pharmaceutical company committed to transforming medicines that transform lives, today announced that it has filed a motion for a preliminary injunction seeking to prevent Par Pharmaceuticals, Inc. from launching a generic version of Treximet.

23 Mar 2011

Study to measure lower pressure's impact on kidney disease, cognitive function

Georgia Health Sciences University is enrolling patients in a federally funded study to determine if a lower blood pressure reduces the progression of kidney disease.

22 Mar 2011

ACE supports HHS' National Strategy for Quality Improvement in Health Care

The Accreditation for Cardiovascular Excellence, a nonprofit organization whose mission is to ensure high-quality patient care and promote patient safety in facilities where invasive cardiac and endovascular procedures are performed, supports the National Strategy for Quality Improvement in Health Care issued today by the U.S. Department of Health and Human Services.

22 Mar 2011

Daily dose of safflower oil can help reduce cardiovascular disease

A daily dose of safflower oil, a common cooking oil, for 16 weeks can improve such health measures as good cholesterol, blood sugar, insulin sensitivity and inflammation in obese postmenopausal women who have Type 2 diabetes, according to new research.

22 Mar 2011

Polypill may serve as viable option for developing countries to treat CVD risk prevention

For a patient at high risk of cardiovascular disease, keeping up with what pills to take at different times of the day can be tedious. Window sills lined with prescription bottles - a pill for cholesterol, another for blood pressure, and an aspirin to keep blood thin and flowing - the list can get quite long and, as a result, many people, especially the elderly, often forget doses or take the wrong pill at the wrong time.

22 Mar 2011

SLEH treats irregular heartbeat with novel minimally invasive cold cryoballoon technology

A physician affiliated with Texas Heart® Institute (THI) at St. Luke's Episcopal Hospital (SLEH) is the first in Houston and among the first in the nation to treat patients for an irregular heartbeat with a new, minimally invasive cryoballoon technology that uses cold rather than heat to interrupt faulty electrical circuits in the heart.

21 Mar 2011

Physical ill-health reduces life expectancy of people with severe mental illness

Physical ill-health is rife among the severely mentally ill in Britain, according to new research published today by the University of East Anglia (UEA).

21 Mar 2011

Tiny Locked Nucleic Acid-based compounds inhibit entire disease-associated microRNA families

A study published online in this week's Nature Genetics demonstrates that tiny Locked Nucleic Acid (LNA)-based compounds developed by Santaris Pharma A/S can inhibit entire disease-associated microRNA families. This provides a potential new approach for treating a variety of diseases including cancer, viral infections, cardiovascular and muscle diseases.

21 Mar 2011

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Statins improve outcomes in high-risk prostate cancer patients treated with definitive radiation therapy

American Heart Association: 81.8% of obese women underestimate their weight

First continuous-flow total artificial heart transplant performed at THI

Specific plant oil may reduce belly fat in humans

Cilag, POZEN enter license agreement to develop and commercialize MT 400

Xenon founder receives Canada Wightman Award for leadership in medical science

Episodic physical and sexual activity associated with short-term increase in risk of acute cardiac events

Obese teens have inflammation, insulin resistance, and high homocysteine levels despite feeling healthy

High-fiber diets during early adult years may reduce lifetime risk of cardiovascular disease

POZEN files motion for Treximet patent litigation against Par

Study to measure lower pressure's impact on kidney disease, cognitive function

ACE supports HHS' National Strategy for Quality Improvement in Health Care

Daily dose of safflower oil can help reduce cardiovascular disease

Polypill may serve as viable option for developing countries to treat CVD risk prevention

SLEH treats irregular heartbeat with novel minimally invasive cold cryoballoon technology

Physical ill-health reduces life expectancy of people with severe mental illness

Tiny Locked Nucleic Acid-based compounds inhibit entire disease-associated microRNA families

EDMA endorses the campaign against excessive use of salt

Asthma an diabetes go hand in hand: Research

Deaths from heart attacks drop precipitously in Norway, reports NTNU researcher

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in